Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2024-02-01

FDA Approved: AZMIRO — Supplemental Application (Azurity Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for AZMIRO (testosterone cypionate) submitted by Azurity Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZMIRO (Testosterone cypionate)

Snippet

SUPPL AP for AZMIRO (TESTOSTERONE CYPIONATE)